Literature DB >> 837646

Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.

A Yacobi, T Lampman, G Levy.   

Abstract

The protein binding of racemic warfarin was determined in serum from 57 normal adults (27 men and 30 women). The free fraction of warfarin (total concentration, 0.8 mug/ml) ranged from 0.0050 to 0.0186 and was log-normally distributed. The frequency distribution differs from that in rats in which the serum free fraction values of warfarin are trimodally distributed. The protein binding of phenytoin was determined in serum from 39 of the subjects. The free fraction of phenytoin (total concentration, 15 mug/ml) ranged from 0.111 to 0.155 and was unimodally distributed. There was no apparent correlation between the extent of protein binding of warfarin and phenytoin in individual serum samples. The pronounced intersubject variation in serum free fraction of warfarin observed in consistent with our previous finding that serum protein binding is an important determinant of interindividual differences in the total clearance of warfarin in man. On the other hand, the relatively narrow distribution of free phenytoin fraction values suggests that differences in serum protein binding of phenytoin are not an important cause of the prounounced interindividual differences in the total clearance of phenytoin by subjects with normal renal function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837646     DOI: 10.1002/cpt1977213283

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

1.  Microdialysis sampling for determination of plasma protein binding of drugs.

Authors:  A M Herrera; D O Scott; C E Lunte
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

Review 2.  Individual differences in the disposition of drugs metabolised in the body.

Authors:  G Alvan
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

3.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

4.  Monitoring free plasma concentrations of phenytoin.

Authors:  G M Peterson; S McLean
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 5.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

6.  Audit of a monitoring service for free phenytoin.

Authors:  G M Peterson; S McLean; R J von Witt; K S Millingen
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

7.  Should we routinely measure free plasma phenytoin concentration?

Authors:  E M Rimmer; D C Buss; P A Routledge; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

8.  Plasma concentrations of unbound phenytoin in the management of epilepsy.

Authors:  C J Kilpatrick; S Wanwimolruk; L M Wing
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

10.  Phenytoin binding to human albumin.

Authors:  M Lecomte; R Zini; P d'Athis; J P Tillement
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.